000821062 001__ 821062
000821062 005__ 20210129224738.0
000821062 0247_ $$2doi$$a10.1126/scisignal.aaf6240
000821062 0247_ $$2ISSN$$a1525-8882
000821062 0247_ $$2ISSN$$a1937-9145
000821062 0247_ $$2ISSN$$a1945-0877
000821062 0247_ $$2WOS$$aWOS:000376467800003
000821062 0247_ $$2altmetric$$aaltmetric:8185622
000821062 0247_ $$2pmid$$apmid:27221710
000821062 037__ $$aFZJ-2016-06306
000821062 082__ $$a500
000821062 1001_ $$0P:(DE-HGF)0$$aDonner, L.$$b0
000821062 245__ $$aPlatelets contribute to amyloid-  aggregation in cerebral vessels through integrin  IIb 3-induced outside-in signaling and clusterin release
000821062 260__ $$aWashington, DC [u.a.]$$bAssoc.$$c2016
000821062 3367_ $$2DRIVER$$aarticle
000821062 3367_ $$2DataCite$$aOutput Types/Journal article
000821062 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1479306609_29797
000821062 3367_ $$2BibTeX$$aARTICLE
000821062 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000821062 3367_ $$00$$2EndNote$$aJournal Article
000821062 520__ $$aCerebral amyloid angiopathy (CAA) is a vascular dysfunction disorder characterized by deposits of amyloid-β (Aβ) in the walls of cerebral vessels. CAA and Aβ deposition in the brain parenchyma contribute to dementia and Alzheimer's disease (AD). We investigated the contribution of platelets, which accumulate at vascular Aβ deposits, to CAA. We found that synthetic monomeric Aβ40 bound through its RHDS (Arg-His-Asp-Ser) sequence to integrin αIIbβ3, which is the receptor for the extracellular matrix protein fibrinogen, and stimulated the secretion of adenosine diphosphate (ADP) and the chaperone protein clusterin from platelets. Clusterin promoted the formation of fibrillar Aβ aggregates, and ADP acted through its receptors P2Y1 and P2Y12 on platelets to enhance integrin αIIbβ3 activation, further increasing the secretion of clusterin and Aβ40 binding to platelets. Platelets from patients with Glanzmann's thrombasthenia, a bleeding disorder in which platelets have little or dysfunctional αIIbβ3, indicated that the abundance of this integrin dictated Aβ-induced clusterin release and platelet-induced Aβ aggregation. The antiplatelet agent clopidogrel, which irreversibly inhibits P2Y12, inhibited Aβ aggregation in platelet cultures; in transgenic AD model mice, this drug reduced the amount of clusterin in the circulation and the incidence of CAA. Our findings indicate that activated platelets directly contribute to CAA by promoting the formation of Aβ aggregates and that Aβ, in turn, activates platelets, creating a feed-forward loop. Thus, antiplatelet therapy may alleviate fibril formation in cerebral vessels of AD patients.
000821062 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000821062 588__ $$aDataset connected to CrossRef
000821062 7001_ $$0P:(DE-HGF)0$$aFalker, K.$$b1
000821062 7001_ $$0P:(DE-Juel1)145165$$aGremer, L.$$b2$$ufzj
000821062 7001_ $$0P:(DE-Juel1)161261$$aKlinker, S.$$b3$$ufzj
000821062 7001_ $$0P:(DE-HGF)0$$aPagani, G.$$b4
000821062 7001_ $$0P:(DE-HGF)0$$aLjungberg, L. U.$$b5
000821062 7001_ $$0P:(DE-HGF)0$$aLothmann, K.$$b6
000821062 7001_ $$0P:(DE-HGF)0$$aRizzi, F.$$b7
000821062 7001_ $$0P:(DE-HGF)0$$aSchaller, M.$$b8
000821062 7001_ $$0P:(DE-HGF)0$$aGohlke, H.$$b9
000821062 7001_ $$0P:(DE-Juel1)132029$$aWillbold, D.$$b10$$ufzj
000821062 7001_ $$0P:(DE-HGF)0$$aGrenegard, M.$$b11
000821062 7001_ $$0P:(DE-HGF)0$$aElvers, M.$$b12$$eCorresponding author
000821062 773__ $$0PERI:(DE-600)2417226-1$$a10.1126/scisignal.aaf6240$$gVol. 9, no. 429, p. ra52 - ra52$$n429$$pra52 - ra52$$tScience signaling$$v9$$x1937-9145$$y2016
000821062 8564_ $$uhttps://juser.fz-juelich.de/record/821062/files/Platelets%20contribute%20to%20amyloid-%20%20aggregation%20in%20cerebral%20vessels%20through%20integrin%20%20IIb%203-induced%20outside-in%20signaling%20and%20clusterin%20release_2016.pdf$$yRestricted
000821062 8564_ $$uhttps://juser.fz-juelich.de/record/821062/files/Platelets%20contribute%20to%20amyloid-%20%20aggregation%20in%20cerebral%20vessels%20through%20integrin%20%20IIb%203-induced%20outside-in%20signaling%20and%20clusterin%20release_2016.gif?subformat=icon$$xicon$$yRestricted
000821062 8564_ $$uhttps://juser.fz-juelich.de/record/821062/files/Platelets%20contribute%20to%20amyloid-%20%20aggregation%20in%20cerebral%20vessels%20through%20integrin%20%20IIb%203-induced%20outside-in%20signaling%20and%20clusterin%20release_2016.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000821062 8564_ $$uhttps://juser.fz-juelich.de/record/821062/files/Platelets%20contribute%20to%20amyloid-%20%20aggregation%20in%20cerebral%20vessels%20through%20integrin%20%20IIb%203-induced%20outside-in%20signaling%20and%20clusterin%20release_2016.jpg?subformat=icon-180$$xicon-180$$yRestricted
000821062 8564_ $$uhttps://juser.fz-juelich.de/record/821062/files/Platelets%20contribute%20to%20amyloid-%20%20aggregation%20in%20cerebral%20vessels%20through%20integrin%20%20IIb%203-induced%20outside-in%20signaling%20and%20clusterin%20release_2016.jpg?subformat=icon-640$$xicon-640$$yRestricted
000821062 8564_ $$uhttps://juser.fz-juelich.de/record/821062/files/Platelets%20contribute%20to%20amyloid-%20%20aggregation%20in%20cerebral%20vessels%20through%20integrin%20%20IIb%203-induced%20outside-in%20signaling%20and%20clusterin%20release_2016.pdf?subformat=pdfa$$xpdfa$$yRestricted
000821062 909CO $$ooai:juser.fz-juelich.de:821062$$pVDB
000821062 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145165$$aForschungszentrum Jülich$$b2$$kFZJ
000821062 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)161261$$aForschungszentrum Jülich$$b3$$kFZJ
000821062 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich$$b10$$kFZJ
000821062 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000821062 9141_ $$y2016
000821062 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000821062 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000821062 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSCI SIGNAL : 2015
000821062 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000821062 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000821062 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bSCI SIGNAL : 2015
000821062 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000821062 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000821062 915__ $$0StatID:(DE-HGF)0550$$2StatID$$aNo Authors Fulltext
000821062 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000821062 920__ $$lyes
000821062 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000821062 980__ $$ajournal
000821062 980__ $$aVDB
000821062 980__ $$aUNRESTRICTED
000821062 980__ $$aI:(DE-Juel1)ICS-6-20110106
000821062 981__ $$aI:(DE-Juel1)IBI-7-20200312